{"transactions":[{"id":742911,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-10T21:24:49.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":8.7,"value":174000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 10, 2026, Chris Rallis was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on date of grant."}],"balance_after":200000,"derivative":{"exercise_price":8.7,"exercise_date":"2026-06-10","expiration_date":"2036-06-10","underlying":"Common shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001185945-26-000004","document":"form4-06102026_090645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000118594526000004/form4-06102026_090645.xml","form_type":"4"}},{"id":782169,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-12T20:05:17.000Z","date":"2026-05-11","kind":"exercise","planned":true,"acquired":false,"shares":14344,"price":2.44,"value":34999.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents options exercised pursuant to a 10b5-1 plan adopted on May 19, 2025."}],"balance_after":186189,"derivative":{"exercise_price":2.44,"exercise_date":"2016-06-09","expiration_date":"2026-06-09","underlying":"Common shares","underlying_shares":14344},"source":{"system":"sec-edgar","filing":"0001185945-26-000002","document":"form4-05122026_040501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000118594526000002/form4-05122026_040501.xml","form_type":"4"}},{"id":782168,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-05-12T20:05:17.000Z","date":"2026-05-11","kind":"sale","planned":true,"acquired":false,"shares":8346,"price":7.04,"value":58755.84,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares sold to satisfy tax obligation on option exercise."}],"balance_after":63077,"source":{"system":"sec-edgar","filing":"0001185945-26-000002","document":"form4-05122026_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000118594526000002/form4-05122026_040501.xml","form_type":"4"}},{"id":782167,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-05-12T20:05:17.000Z","date":"2026-05-11","kind":"exercise","planned":true,"acquired":true,"shares":14344,"price":2.44,"value":34999.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on May 19, 2025."}],"balance_after":71423,"source":{"system":"sec-edgar","filing":"0001185945-26-000002","document":"form4-05122026_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000118594526000002/form4-05122026_040501.xml","form_type":"4"}},{"id":1019098,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-10-14T20:10:05.000Z","date":"2025-10-10","kind":"exercise","planned":true,"acquired":false,"shares":4062,"price":1.23,"value":4996.26,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents options exercised pursuant to a 10b5-1 plan adopted on May 19, 2025."}],"balance_after":174344,"derivative":{"exercise_price":1.23,"exercise_date":"2015-11-10","expiration_date":"2025-11-10","underlying":"Options","underlying_shares":4062},"source":{"system":"sec-edgar","filing":"0001185945-25-000005","document":"form4-10142025_041001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000118594525000005/form4-10142025_041001.xml","form_type":"4"}},{"id":1019097,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-10-14T20:10:05.000Z","date":"2025-10-10","kind":"sale","planned":true,"acquired":false,"shares":1775,"price":9.24,"value":16401.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares sold to satisfy tax obligation on option exercise."}],"balance_after":57079,"source":{"system":"sec-edgar","filing":"0001185945-25-000005","document":"form4-10142025_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000118594525000005/form4-10142025_041001.xml","form_type":"4"}},{"id":1019096,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-10-14T20:10:05.000Z","date":"2025-10-10","kind":"exercise","planned":true,"acquired":true,"shares":4062,"price":1.23,"value":4996.26,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on May 19, 2025."}],"balance_after":58854,"source":{"system":"sec-edgar","filing":"0001185945-25-000005","document":"form4-10142025_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000118594525000005/form4-10142025_041001.xml","form_type":"4"}},{"id":1091188,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-07-07T21:31:13.000Z","date":"2025-07-07","kind":"exercise","planned":true,"acquired":false,"shares":2127,"price":2.35,"value":4998.45,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023."}],"balance_after":178406,"derivative":{"exercise_price":2.35,"exercise_date":"2015-08-03","expiration_date":"2025-08-03","underlying":"Options","underlying_shares":2127},"source":{"system":"sec-edgar","filing":"0001415889-25-019433","document":"form4-07072025_090710.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588925019433/form4-07072025_090710.xml","form_type":"4"}},{"id":1091187,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-07-07T21:31:13.000Z","date":"2025-07-07","kind":"sale","planned":true,"acquired":false,"shares":1119,"price":8.71,"value":9746.49,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares sold to satisfy tax obligation on option exercise."}],"balance_after":54792,"source":{"system":"sec-edgar","filing":"0001415889-25-019433","document":"form4-07072025_090710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588925019433/form4-07072025_090710.xml","form_type":"4"}},{"id":1091186,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-07-07T21:31:13.000Z","date":"2025-07-07","kind":"exercise","planned":true,"acquired":true,"shares":2127,"price":2.35,"value":4998.45,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023."}],"balance_after":55911,"source":{"system":"sec-edgar","filing":"0001415889-25-019433","document":"form4-07072025_090710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588925019433/form4-07072025_090710.xml","form_type":"4"}},{"id":1122615,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-04T20:20:10.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":7.88,"value":157600.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 3, 2025, Chris Rallis was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on date of grant."}],"balance_after":200533,"derivative":{"exercise_price":7.88,"exercise_date":"2025-06-03","expiration_date":"2035-06-03","underlying":"Common shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-25-015587","document":"form4-06042025_040604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588925015587/form4-06042025_040604.xml","form_type":"4"}},{"id":1173219,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-04-11T20:31:00.000Z","date":"2025-04-11","kind":"exercise","planned":true,"acquired":false,"shares":2173,"price":2.3,"value":4997.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023."}],"balance_after":180533,"derivative":{"exercise_price":2.3,"exercise_date":"2015-05-11","expiration_date":"2025-05-11","underlying":"Options","underlying_shares":2173},"source":{"system":"sec-edgar","filing":"0001415889-25-010574","document":"form4-04112025_080457.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588925010574/form4-04112025_080457.xml","form_type":"4"}},{"id":1173218,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-04-11T20:31:00.000Z","date":"2025-04-11","kind":"sale","planned":true,"acquired":false,"shares":1409,"price":4.95,"value":6974.55,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares sold to satisfy tax obligation on option exercise."}],"balance_after":53784,"source":{"system":"sec-edgar","filing":"0001415889-25-010574","document":"form4-04112025_080457.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588925010574/form4-04112025_080457.xml","form_type":"4"}},{"id":1173217,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-04-11T20:31:00.000Z","date":"2025-04-11","kind":"exercise","planned":true,"acquired":true,"shares":2173,"price":2.3,"value":4997.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":". Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023."}],"balance_after":55193,"source":{"system":"sec-edgar","filing":"0001415889-25-010574","document":"form4-04112025_080457.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588925010574/form4-04112025_080457.xml","form_type":"4"}},{"id":1266930,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-02-14T23:13:50.000Z","date":"2025-02-14","kind":"exercise","planned":true,"acquired":false,"shares":1992,"price":2.51,"value":4999.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023."}],"balance_after":182706,"derivative":{"exercise_price":2.51,"exercise_date":"2015-03-16","expiration_date":"2025-03-16","underlying":"Options","underlying_shares":1992},"source":{"system":"sec-edgar","filing":"0001415889-25-004249","document":"form4-02142025_110245.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588925004249/form4-02142025_110245.xml","form_type":"4"}},{"id":1266929,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-02-14T23:13:50.000Z","date":"2025-02-14","kind":"sale","planned":true,"acquired":false,"shares":1186,"price":6.82,"value":8088.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares sold to satisfy tax obligation on option exercise."}],"balance_after":53020,"source":{"system":"sec-edgar","filing":"0001415889-25-004249","document":"form4-02142025_110245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588925004249/form4-02142025_110245.xml","form_type":"4"}},{"id":1266928,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-02-14T23:13:50.000Z","date":"2025-02-14","kind":"exercise","planned":true,"acquired":true,"shares":1992,"price":2.51,"value":4999.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023."}],"balance_after":54206,"source":{"system":"sec-edgar","filing":"0001415889-25-004249","document":"form4-02142025_110245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588925004249/form4-02142025_110245.xml","form_type":"4"}},{"id":1347033,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-12-03T00:07:34.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":2.69,"value":26900.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023."}],"balance_after":184698,"derivative":{"exercise_price":2.69,"exercise_date":"2014-12-31","expiration_date":"2024-12-31","underlying":"Options","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-028018","document":"form4-12032024_121231.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588924028018/form4-12032024_121231.xml","form_type":"4"}},{"id":1347032,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-12-03T00:07:34.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":6409,"price":6.14,"value":39351.26,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares sold to satisfy tax obligation on option exercise."}],"balance_after":52214,"source":{"system":"sec-edgar","filing":"0001415889-24-028018","document":"form4-12032024_121231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588924028018/form4-12032024_121231.xml","form_type":"4"}},{"id":1347031,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-12-03T00:07:34.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":2.69,"value":26900.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023."}],"balance_after":58623,"source":{"system":"sec-edgar","filing":"0001415889-24-028018","document":"form4-12032024_121231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588924028018/form4-12032024_121231.xml","form_type":"4"}},{"id":1388051,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-10-10T21:14:40.000Z","date":"2024-10-08","kind":"exercise","planned":true,"acquired":false,"shares":1960,"price":2.55,"value":4998.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023."}],"balance_after":194698,"derivative":{"exercise_price":2.55,"exercise_date":"2014-11-07","expiration_date":"2024-11-07","underlying":"Options","underlying_shares":1960},"source":{"system":"sec-edgar","filing":"0001415889-24-024986","document":"form4-10102024_091037.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588924024986/form4-10102024_091037.xml","form_type":"4"}},{"id":1388050,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-10-10T21:14:40.000Z","date":"2024-10-08","kind":"sale","planned":true,"acquired":false,"shares":1406,"price":4.53,"value":6369.18,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares sold to satisfy tax obligation on option exercise."}],"balance_after":48623,"source":{"system":"sec-edgar","filing":"0001415889-24-024986","document":"form4-10102024_091037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588924024986/form4-10102024_091037.xml","form_type":"4"}},{"id":1388049,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-10-10T21:14:40.000Z","date":"2024-10-08","kind":"exercise","planned":true,"acquired":true,"shares":1960,"price":2.55,"value":4998.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023."}],"balance_after":50029,"source":{"system":"sec-edgar","filing":"0001415889-24-024986","document":"form4-10102024_091037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588924024986/form4-10102024_091037.xml","form_type":"4"}},{"id":1429044,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-08-19T23:00:06.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":5.58,"value":111600.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 15, 2024, Chris Rallis was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested of date of grant."}],"balance_after":196658,"derivative":{"exercise_price":5.58,"exercise_date":"2024-08-15","expiration_date":"2034-08-15","underlying":"Common shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-021638","document":"form4-08192024_110803.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588924021638/form4-08192024_110803.xml","form_type":"4"}},{"id":1458202,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-07-08T20:05:08.000Z","date":"2024-07-05","kind":"exercise","planned":true,"acquired":false,"shares":1792,"price":2.79,"value":4999.68,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents options exercised pursuant to a 10b5-1 program adopted August 17, 2023."}],"balance_after":179802,"derivative":{"exercise_price":2.79,"exercise_date":"2014-08-04","expiration_date":"2024-08-04","underlying":"Options","underlying_shares":1792},"source":{"system":"sec-edgar","filing":"0001415889-24-019332","document":"form4-07082024_040704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588924019332/form4-07082024_040704.xml","form_type":"4"}},{"id":1458201,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-07-08T20:05:08.000Z","date":"2024-07-05","kind":"sale","planned":true,"acquired":false,"shares":1173,"price":6.03,"value":7073.19,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares sold to satisfy tax obligation on option exercise."}],"balance_after":46457,"source":{"system":"sec-edgar","filing":"0001415889-24-019332","document":"form4-07082024_040704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588924019332/form4-07082024_040704.xml","form_type":"4"}},{"id":1458200,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-07-08T20:05:08.000Z","date":"2024-07-05","kind":"exercise","planned":true,"acquired":true,"shares":1792,"price":2.79,"value":4999.68,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023."}],"balance_after":47630,"source":{"system":"sec-edgar","filing":"0001415889-24-019332","document":"form4-07082024_040704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588924019332/form4-07082024_040704.xml","form_type":"4"}},{"id":1541817,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-04-15T22:15:20.000Z","date":"2024-04-15","kind":"exercise","planned":true,"acquired":false,"shares":1389,"price":3.6,"value":5000.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents options exercised pursuant to a 10b5-1 program adopted August 17, 2023."}],"balance_after":181594,"derivative":{"exercise_price":3.6,"exercise_date":"2014-05-15","expiration_date":"2024-05-15","underlying":"Options","underlying_shares":1389},"source":{"system":"sec-edgar","filing":"0001415889-24-010817","document":"form4-04152024_100414.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588924010817/form4-04152024_100414.xml","form_type":"4"}},{"id":1541816,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-04-15T22:15:20.000Z","date":"2024-04-15","kind":"exercise","planned":true,"acquired":true,"shares":1389,"price":10.45,"value":14515.05,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023."}],"balance_after":45838,"source":{"system":"sec-edgar","filing":"0001415889-24-010817","document":"form4-04152024_100414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588924010817/form4-04152024_100414.xml","form_type":"4"}},{"id":1541815,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-04-15T22:15:20.000Z","date":"2024-04-15","kind":"sale","planned":true,"acquired":false,"shares":800,"price":10.45,"value":8360.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares sold to satisfy tax obligation on option exercise."}],"balance_after":44449,"source":{"system":"sec-edgar","filing":"0001415889-24-010817","document":"form4-04152024_100414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588924010817/form4-04152024_100414.xml","form_type":"4"}},{"id":1559363,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-03-27T20:24:10.000Z","date":"2024-03-26","kind":"exercise","planned":true,"acquired":false,"shares":4329,"price":2.31,"value":9999.99,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023."}],"balance_after":182983,"derivative":{"exercise_price":2.31,"exercise_date":"2014-04-24","expiration_date":"2024-04-25","underlying":"Options","underlying_shares":4239},"source":{"system":"sec-edgar","filing":"0001415889-24-009205","document":"form4-03272024_080358.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588924009205/form4-03272024_080358.xml","form_type":"4"}},{"id":1559362,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-03-27T20:24:10.000Z","date":"2024-03-26","kind":"exercise","planned":true,"acquired":true,"shares":4329,"price":2.31,"value":9999.99,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired through the exercise of an option pusuant to a 10b5-1 plan adopted on August 17, 2023."}],"balance_after":45249,"source":{"system":"sec-edgar","filing":"0001415889-24-009205","document":"form4-03272024_080358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588924009205/form4-03272024_080358.xml","form_type":"4"}},{"id":1559361,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-03-27T20:24:10.000Z","date":"2024-03-26","kind":"sale","planned":true,"acquired":false,"shares":2114,"price":10.97,"value":23190.58,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares sold to satisfy tax obligation on option exercise."}],"balance_after":40920,"source":{"system":"sec-edgar","filing":"0001415889-24-009205","document":"form4-03272024_080358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588924009205/form4-03272024_080358.xml","form_type":"4"}},{"id":1698480,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-12-28T21:02:09.000Z","date":"2023-12-26","kind":"exercise","planned":true,"acquired":false,"shares":3144,"price":1.59,"value":4998.96,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired through the exercise of an option contract with strike price of $1.59 and an expiration date of January 24, 2024."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents options granted on January 24, 2014, with a strike price of $1.59 and expiration date of January 24, 2024."}],"balance_after":184168,"derivative":{"exercise_price":1.59,"exercise_date":"2014-01-24","expiration_date":"2024-01-24","underlying":"Options","underlying_shares":3144},"source":{"system":"sec-edgar","filing":"0001104659-23-130042","document":"tm2333865-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000110465923130042/tm2333865-1_4seq1.xml","form_type":"4"}},{"id":1698479,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-12-28T21:02:09.000Z","date":"2023-12-26","kind":"exercise","planned":true,"acquired":true,"shares":3144,"price":1.59,"value":4998.96,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired through the exercise of an option contract with strike price of $1.59 and an expiration date of January 24, 2024."}],"balance_after":46178,"source":{"system":"sec-edgar","filing":"0001104659-23-130042","document":"tm2333865-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000110465923130042/tm2333865-1_4seq1.xml","form_type":"4"}},{"id":1698478,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-12-28T21:02:09.000Z","date":"2023-12-26","kind":"sale","planned":true,"acquired":false,"shares":1390,"price":10.9,"value":15151.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares sold to satisfy tax obligation on option exercise."}],"balance_after":44788,"source":{"system":"sec-edgar","filing":"0001104659-23-130042","document":"tm2333865-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000110465923130042/tm2333865-1_4seq1.xml","form_type":"4"}},{"id":1734310,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-11-21T02:20:08.000Z","date":"2023-11-20","kind":"sale","planned":true,"acquired":false,"shares":269,"price":8.25,"value":2219.25,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares sold pursuant to a 10b5-1 agreement dated March 18, 2022. Sharee sold at a price of $8.25."}],"balance_after":43034,"source":{"system":"sec-edgar","filing":"0001415889-23-015314","document":"form4-11202023_091101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588923015314/form4-11202023_091101.xml","form_type":"4"}},{"id":1801710,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-08-18T21:00:11.000Z","date":"2023-08-18","kind":"sale","planned":true,"acquired":false,"shares":673,"price":7.85,"value":5283.05,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares originally acquired through the exercise of an option with strike price of $0.45, and an original expiration date of August 17, 2022."}],"balance_after":43303,"source":{"system":"sec-edgar","filing":"0001415889-23-012411","document":"form4-08182023_050802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588923012411/form4-08182023_050802.xml","form_type":"4"}},{"id":1824104,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-07-24T21:04:32.000Z","date":"2023-07-24","kind":"exercise","planned":true,"acquired":false,"shares":16666,"price":0.72,"value":11999.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents options granted on August 23, 2013, with a strike price of $0.72 and an expiration date of August 23, 2023."}],"balance_after":187312,"derivative":{"exercise_price":0.72,"exercise_date":"2013-08-06","expiration_date":"2023-08-06","underlying":"Options","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001415889-23-011416","document":"form4-07242023_090724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588923011416/form4-07242023_090724.xml","form_type":"4"}},{"id":1824103,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-07-24T21:04:32.000Z","date":"2023-07-24","kind":"sale","planned":true,"acquired":false,"shares":6796,"price":8.17,"value":55523.32,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares sold to satisfy tax obligation on option exercise."}],"balance_after":43976,"source":{"system":"sec-edgar","filing":"0001415889-23-011416","document":"form4-07242023_090724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588923011416/form4-07242023_090724.xml","form_type":"4"}},{"id":1824102,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-07-24T21:04:32.000Z","date":"2023-07-24","kind":"exercise","planned":true,"acquired":true,"shares":16666,"price":0.72,"value":11999.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $0.72 and an expiration date of August 23, 2023."}],"balance_after":50772,"source":{"system":"sec-edgar","filing":"0001415889-23-011416","document":"form4-07242023_090724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588923011416/form4-07242023_090724.xml","form_type":"4"}},{"id":1833600,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-07-06T21:20:41.000Z","date":"2023-07-06","kind":"exercise","planned":true,"acquired":false,"shares":5208,"price":0.96,"value":4999.68,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents options granted on August 6, 2013, with a strike price of $0.96 and expiration date of August 6, 2023."}],"balance_after":203978,"derivative":{"exercise_price":0.96,"exercise_date":"2013-08-06","expiration_date":"2023-08-06","underlying":"Options","underlying_shares":5208},"source":{"system":"sec-edgar","filing":"0001415889-23-010905","document":"form4-07062023_090736.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588923010905/form4-07062023_090736.xml","form_type":"4"}},{"id":1833599,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-07-06T21:20:41.000Z","date":"2023-07-06","kind":"exercise","planned":true,"acquired":true,"shares":5280,"price":0.96,"value":5068.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired through the exercise of an option contract with strike price of $0.96 and an expiration date of August 6, 2023."}],"balance_after":34106,"source":{"system":"sec-edgar","filing":"0001415889-23-010905","document":"form4-07062023_090736.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588923010905/form4-07062023_090736.xml","form_type":"4"}},{"id":1833598,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-07-06T21:20:41.000Z","date":"2023-07-06","kind":"sale","planned":true,"acquired":false,"shares":2207,"price":8.47,"value":18693.29,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares sold to satisfy tax obligation on option exercise."}],"balance_after":28826,"source":{"system":"sec-edgar","filing":"0001415889-23-010905","document":"form4-07062023_090736.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588923010905/form4-07062023_090736.xml","form_type":"4"}},{"id":1857038,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-06-13T15:42:04.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 12, 2023, Chris Rallis was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested of date of grant."}],"balance_after":209186,"derivative":{"exercise_price":8.78,"exercise_date":"2023-06-12","expiration_date":"2033-06-12","underlying":"Common shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-23-009702","document":"form4-06132023_030600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588923009702/form4-06132023_030600.xml","form_type":"4"}},{"id":1884274,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-05-19T20:41:58.000Z","date":"2023-05-19","kind":"sale","planned":true,"acquired":false,"shares":925,"price":7.36,"value":6808.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Sale of common shares sold in accordance with 10b5-1 plan. Commom shares resulted from exercise of option grant with grant date of 5/17/2012."}],"balance_after":31033,"source":{"system":"sec-edgar","filing":"0001415889-23-008417","document":"form4-05192023_080541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588923008417/form4-05192023_080541.xml","form_type":"4"}},{"id":1884273,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-05-19T20:41:58.000Z","date":"2023-05-19","kind":"sale","planned":true,"acquired":false,"shares":833,"price":7.36,"value":6130.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of common shares sold in accordance with 10b5-1 plan. Commom shares resulted from exercise of option grant with grant date of 4/4/2012."}],"balance_after":31958,"source":{"system":"sec-edgar","filing":"0001415889-23-008417","document":"form4-05192023_080541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588923008417/form4-05192023_080541.xml","form_type":"4"}},{"id":1918898,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-04-18T01:25:05.000Z","date":"2023-04-17","kind":"tax_withholding","planned":true,"acquired":false,"shares":986,"price":8.34,"value":8223.24,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares automatically sold pursuant to a 10b5-1 plan to an irrevocable sell to cover election to satisfy tax withholding obligation in connectionwith the exercise of 1,700 shares from a May 2013 grant."}],"balance_after":32791,"source":{"system":"sec-edgar","filing":"0001415889-23-006577","document":"form4-04182023_010400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588923006577/form4-04182023_010400.xml","form_type":"4"}},{"id":1918897,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-04-18T01:25:05.000Z","date":"2023-04-17","kind":"exercise","planned":true,"acquired":true,"shares":1700,"price":2.94,"value":4998.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents options granted May 17, 2013, with a $2.94 strike price aand expiration of May 17, 2023."}],"balance_after":33777,"source":{"system":"sec-edgar","filing":"0001415889-23-006577","document":"form4-04182023_010400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588923006577/form4-04182023_010400.xml","form_type":"4"}},{"id":1972484,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-03-03T22:35:20.000Z","date":"2023-03-03","kind":"tax_withholding","acquired":false,"shares":2177,"price":9.09,"value":19788.93,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares automatically sold pursuant to a 10b5-1 plan to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the exercise of 4,166 shares from an April 3, 2013 grant."}],"balance_after":32077,"source":{"system":"sec-edgar","filing":"0001415889-23-004182","document":"form4-03032023_100359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588923004182/form4-03032023_100359.xml","form_type":"4"}},{"id":1972483,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-03-03T22:35:20.000Z","date":"2023-03-03","kind":"exercise","acquired":true,"shares":4166,"price":2.4,"value":9998.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents options granted April 3, 2013, with a $2.40 USD strike price and expiration of April 3, 2023."}],"balance_after":34184,"source":{"system":"sec-edgar","filing":"0001415889-23-004182","document":"form4-03032023_100359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588923004182/form4-03032023_100359.xml","form_type":"4"}},{"id":2111839,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-11-17T21:09:50.000Z","date":"2022-11-17","kind":"sale","acquired":false,"shares":333,"price":7.99,"value":2660.67,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares sold pursuant to a 10b5-1 plan on November 17, 2022."}],"balance_after":30018,"source":{"system":"sec-edgar","filing":"0001415889-22-011492","document":"form4-11172022_091140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588922011492/form4-11172022_091140.xml","form_type":"4"}},{"id":2134091,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-20T20:15:08.000Z","date":"2022-10-20","kind":"tax_withholding","acquired":false,"shares":2068,"price":8.26,"value":17081.68,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares automatically sold pursuant to a 10b5-1 plan to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the exercise of 4,762 shares from an November 11, 2012 grant."}],"balance_after":30351,"source":{"system":"sec-edgar","filing":"0001415889-22-010738","document":"form4-10202022_011051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588922010738/form4-10202022_011051.xml","form_type":"4"}},{"id":2134090,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-20T20:15:08.000Z","date":"2022-10-20","kind":"exercise","acquired":true,"shares":4762,"price":1.05,"value":5000.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents options granted on November 11, 2012, with a $1.05 USD strike price and an expiration of November 11, 2022."}],"balance_after":32419,"source":{"system":"sec-edgar","filing":"0001415889-22-010738","document":"form4-10202022_011051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000141588922010738/form4-10202022_011051.xml","form_type":"4"}},{"id":2206209,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-07-18T22:00:39.000Z","date":"2022-07-18","kind":"tax_withholding","acquired":false,"shares":4379,"price":6.7,"value":29339.3,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares automatically sold pursuant to a 10b5-1 plan to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the exercise of 11,111 shares from an August 17, 2012 grant."}],"balance_after":27657,"source":{"system":"sec-edgar","filing":"0001104659-22-080585","document":"tm2221334-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000110465922080585/tm2221334-1_4seq1.xml","form_type":"4"}},{"id":2206208,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-07-18T22:00:39.000Z","date":"2022-07-18","kind":"exercise","acquired":true,"shares":11111,"price":0.45,"value":4999.95,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents options granted on August 17, 2012, with a $0.45 USD strike price and an expiration of August 17, 2022."}],"balance_after":32036,"source":{"system":"sec-edgar","filing":"0001104659-22-080585","document":"tm2221334-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000110465922080585/tm2221334-1_4seq1.xml","form_type":"4"}},{"id":2229725,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T13:26:31.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 14, 2022, Chris Rallis was granted a non-statutory stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":5.59,"expiration_date":"2032-06-14","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-071690","document":"tm2218610-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000110465922071690/tm2218610-5_4seq1.xml","form_type":"4"}},{"id":2344079,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T13:24:56.000Z","date":"2022-03-08","kind":"exercise","acquired":true,"shares":9259,"price":0.54,"value":4999.86,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents options granted on May 17, 2012, with a $0.54 USD strike price and an expiration of May17, 2022."}],"balance_after":20925,"source":{"system":"sec-edgar","filing":"0001104659-22-031286","document":"tm228629-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000110465922031286/tm228629-1_4seq1.xml","form_type":"4"}},{"id":2344078,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-08T13:24:56.000Z","date":"2022-03-08","kind":"exercise","acquired":true,"shares":8333,"price":0.6,"value":4999.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents options granted on April 4, 2012, with a $0.60 USD strike price and an expiration of April 4, 2022."}],"balance_after":11666,"source":{"system":"sec-edgar","filing":"0001104659-22-031286","document":"tm228629-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000110465922031286/tm228629-1_4seq1.xml","form_type":"4"}},{"id":2537247,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-10-21T19:40:03.000Z","date":"2021-10-21","kind":"exercise","acquired":true,"shares":3333,"price":1.5,"value":4999.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents options granted on November 18, 2011, with a $1.50 USD strike price and an expiration of November 18, 2021."}],"balance_after":3333,"source":{"system":"sec-edgar","filing":"0001104659-21-128430","document":"tm2130788-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000110465921128430/tm2130788-1_4seq1.xml","form_type":"4"}},{"id":2649586,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-30T19:44:27.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 29, 2021, Chris Rallis was granted a non-statutory stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":7.52,"expiration_date":"2031-06-29","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-21-087517","document":"tm2121155-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000110465921087517/tm2121155-5_4seq1.xml","form_type":"4"}},{"id":3057090,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-08-14T19:18:08.000Z","date":"2020-08-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 13, 2020, Chris Rallis was granted a non-statutory stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":6.17,"expiration_date":"2030-08-13","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-20-095451","document":"tm2027709d5_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000110465920095451/tm2027709d5_4.xml","form_type":"4"}},{"id":3111309,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2020-06-15T20:30:31.000Z","date":"2019-05-01","kind":"grant","acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":500,"derivative":{"exercise_price":1.72,"exercise_date":"2020-05-01","expiration_date":"2029-05-01","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001654954-20-006645","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495420006645/section16.xml","form_type":"4"}},{"id":3111308,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2020-06-15T20:30:31.000Z","date":"2020-05-01","kind":"grant","acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":500,"derivative":{"exercise_price":0.66,"exercise_date":"2021-05-01","expiration_date":"2030-05-01","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001654954-20-006645","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495420006645/section16.xml","form_type":"4"}},{"id":3483863,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-20T00:34:21.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 18, 2019, Chris Rallis was granted an incentive stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Amended and Restated Stock Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":4.26,"expiration_date":"2029-06-18","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-19-031566","document":"tv523895_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000114420419031566/tv523895_4.xml","form_type":"4"}},{"id":3898156,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-11T14:40:53.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 8, 2018, Chris A. Rallis was granted an incentive stock option to purchase 20,000 common shares of the Issuer pursuant to the Issuer's Amended and Restated Stock Option Plan.  The option is 100% vested on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":10.93,"exercise_date":"2018-06-08","expiration_date":"2025-06-08","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-18-033676","document":"tv496269_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000114420418033676/tv496269_4.xml","form_type":"4"}}]}